IKBKG Monoklonaler Antikörper
IKBKG Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1F2E2
Kat-Nr. : 66460-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66460-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA IKBKG und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | IKBKG fusion protein Ag13358 |
| Vollständiger Name | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
| Berechnetes Molekulargewicht | 48 kDa |
| Beobachtetes Molekulargewicht | 48 kDa |
| GenBank-Zugangsnummer | BC012114 |
| Gene symbol | IKBKG |
| Gene ID (NCBI) | 8517 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
IKBKG, also named as FIP3, NEMO, IKKAP1 and IKKG, is specifically phosphorylate serine or threonine residues that are followed by a proline residue. IKBKG is regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Its binding to scaffolding polyubiquitin seems to play a role in IKK activation by multiple signaling receptor pathways.







